1. P542 Short term efficacy, safety and thromboembolic risk of tofacitinib in moderate to severe Ulcerative Colitis. (30th January 2023) Authors: Cingolani, L; Barberio, B; Zelante, A; Ribaldone, D; Testa, G; Bertani, L; Buda, A; Zingone, F; Savarino, E V Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗